文献速递眼底病与葡萄膜炎

增殖性玻璃体视网膜病变中核心蛋白聚糖生物学改变:机制与队列研究

Altered Decorin Biology in Proliferative Vitreoretinopathy: A Mechanistic and Cohort Study.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2018-01-01

该研究结合体外实验与前瞻性非干预队列,探讨玻璃体TGF-β2及核心蛋白聚糖(decorin)能否预测孔源性视网膜脱离(RRD)术后增殖性玻璃体视网膜病变(PVR)的发生。体外实验显示TGF-β2诱导上皮-间质转化(EMT)和胶原产生,高浓度decorin可抑制EMT和胶原产生。队列纳入125例接受玻璃体切割术的RRD及黄斑裂孔患者,随访6个月,发现RRD后发生PVR者玻璃体平均decorin水平高于未发生者,但在测得的玻璃体浓度(1-2 μg/mL)下decorin体外未显示抑制EMT的作用,且不能可靠预测PVR结局。

要点

  • 体外高浓度decorin抑制TGF-β2诱导的EMT和胶原产生。
  • 人玻璃体浓度(1-2 μg/mL)下decorin体外未显示抑制EMT的作用。
  • RRD术后发生PVR者初始玻璃体平均decorin水平较高,但不能可靠预测PVR。

核心结论

  • 体外高浓度decorin抑制EMT和纤维化,但在人玻璃体浓度下decorin体外未能预防纤维化或EMT。
  • RRD玻璃体切割术后发生PVR者初始玻璃体decorin水平较高,但decorin不能可靠预测PVR结局。

研究设计与样本

  • 体外实验使用ARPE-19细胞检测TGF-β2和decorin对EMT及胶原表达的影响,并分析PVR膜与内界膜患者样本的细胞外基质标志物表达。
  • 前瞻性非干预队列研究纳入125例接受玻璃体切割术的RRD和黄斑裂孔手术患者,用ELISA测定玻璃体TGF-β2和decorin水平,随访6个月。

主要发现

  • 体外TGF-β2诱导EMT和胶原产生,高浓度decorin强烈抑制EMT和胶原产生。
  • PVR膜表达高水平纤维化相关蛋白,与EMT一致。
  • 黄斑裂孔患者与RRD患者(无论其后是否发生PVR)之间玻璃体TGF-β2水平无变化。
  • RRD后发生PVR者玻璃体平均decorin水平高于未发生者,但在测得的玻璃体浓度(1-2 μg/mL)下decorin体外未显示抑制EMT的作用。

临床怎么用

  • 玻璃体decorin水平可能提示RRD术后PVR风险,但尚不能作为可靠预测指标用于临床决策。
  • decorin在生理玻璃体浓度下体外未显示抗EMT作用,针对decorin通路的治疗策略需进一步验证。

局限性

  • decorin在测得的玻璃体浓度(1-2 μg/mL)下体外未显示抑制EMT作用,体外高浓度结果不能直接外推至人体玻璃体环境。
  • decorin水平与PVR发生相关但不能可靠预测结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine if vitreous levels of the pro-fibrotic cytokine transforming growth factor beta2 (TGF-β2) and its opposing regulator decorin predict subsequent proliferative vitreoretinopathy (PVR) development in patients with rhegmatogenous retinal detachment (RRD). METHODS: We examined the effect of TGF-β2 and decorin on epithelial-mesenchymal transition (EMT) and collagen expression in vitro using ARPE-19 cells, and we analyzed extracellular matrix marker expression in PVR membrane and internal limiting membrane patient samples. We performed a prospective noninterventional cohort study, recruiting 125 patients undergoing vitrectomy for RRD and macular hole surgery, measured vitreous levels of TGF-β2 and decorin by ELISA, and followed them up for 6 months. Patients who did not develop PVR were compared to those who did, in order to determine whether vitreous TGF-β2 and decorin levels predicted PVR development. RESULTS: In vitro, TGF-β2 induced EMT and collagen production. Decorin strongly inhibited EMT and collagen production at high levels. PVR membranes expressed high levels of fibrosis-associated proteins, consistent with EMT. Vitreous TGF-β2 levels were unchanged between patients with macular holes and RRD who did or did not subsequently develop PVR. Average decorin levels were higher in the vitreous of RRD patients who subsequently developed PVR compared to those who did not, but at the measured vitreous concentrations (1-2 μg/mL), decorin did not demonstrate an in vitro inhibitory effect on EMT. CONCLUSIONS: In vitro, high concentrations of decorin inhibited EMT and fibrosis. At the levels seen in human vitreous, decorin did not prevent fibrosis or EMT in vitro, and higher initial vitreous decorin levels were associated with the development of postoperative PVR after vitrectomy to treat RRD, but did not reliably predict the outcome.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Begum G, O'Neill J, Chaudhary R, et al. Altered Decorin Biology in Proliferative Vitreoretinopathy: A Mechanistic and Cohort Study. Invest Ophthalmol Vis Sci. 2018. PMID: 30347087. doi:10.1167/iovs.18-24299

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。